High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells

FASEB Journal

Volumn 27, Issue 4, 2013, Pages 1413-1425

  Van Der Vorst, Emiel P C ^a,b   Vanags, Laura Z ^a,c   Dunn, Louise L ^a   Prosser, Hamish C ^a   Rye, Kerry Anne ^a,c,d   Bursill, Christina A ^a,c  

^a HEART RESEARCH INSTITUTE   (Australia)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Inflammation; Scavenger receptor B1

Indexed keywords

APOLIPOPROTEIN A1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; HIGH DENSITY LIPOPROTEIN; I KAPPA B ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLCHOLINE; PROTEIN KINASE B; RANTES; SCAVENGER RECEPTOR BI; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LEVEL; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

APOLIPOPROTEIN A-I; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CX3CL1; CHEMOKINES; HUMANS; LIPOPROTEINS, HDL; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CCR2; RECEPTORS, CHEMOKINE; TUMOR NECROSIS FACTOR-ALPHA;

SECALE CEREALE;

EID: 84875701972     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-212753     Document Type: Article

References (39)

1. Rye, K. A., Bursill, C. A., Labert, G., Tabet, F., and Barter, P. J. (2009) The metabolism and anti-atherogenic properties of HDL. J. Lipid Res. 50(Suppl.), S195-S200.
2. Barter, P. J., Nicholls, S., Rye, K. A., Anantharamaiah, G. M., Navab, M., and Fogelman, A. M. (2004) Anti-inflammatory properties of HDL. Circ. Res. 95, 764-772.
3. Charo, I. F., and Ransohoff, R. M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621.
4. Schober, A. (2008) Chemokines in vascular dysfunction and remodeling. Arterioscler. Thromb. Vasc. Biol. 28, 1950-1959.
5. Selzman, C. H., Miller, S. A., Zimmerman, M. A., Gamboni- Robertson, F., Harken, A. H., and Banerjee, A. (2002) Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am. J. Physiol. Heart Circ. Physiol. 283, H1455-H1461.
6. White, G. E., Tan, T. C., John, A. E., Whatling, C., McPheat, W. L., and Greaves, D. R. (2010) Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc. Res. 85, 825-835.
7. Kovacic, J. C., Gupta, R., Lee, A. C., Ma, M., Fang, F., Tolbert, C. N., Walts, A. D., Beltran, L. E., San, H., Chen, G., St Hilaire, C., and Boehm, M. (2010) Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J. Clin. Invest. 120, 303-314.
8. Chandrasekar, B., Mummidi, S., Perla, R. P., Bysani, S., Dulin, N. O., Liu, F., and Melby, P. C. (2003) Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem. J. 373, 547-558.
9. Furukawa, Y., Matsumori, A., Ohashi, N., Shioi, T., Ono, K., Harada, A., Matsushima, K., and Sasayama, S. (1999) Antimonocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ. Res. 84, 306-314.
10. Taubman, M. B., Rollins, B. J., Poon, M., Marmur, J., Green, R. S., Berk, B. C., and Nadal-Ginard, B. (1992) JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ. Res. 70, 314-325.
11. Schober, A., Zernecke, A., Liehn, E. A., von Hundelshausen, P., Knarren, S., Kuziel, W. A., and Weber, C. (2004) Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ. Res. 95, 1125- 1133.
12. Zernecke, A., Liehn, E. A., Gao, J. L., Kuziel, W. A., Murphy, P. M., and Weber, C. (2006) Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 107, 4240-4243.
13. Roque, M., Kim, W. J., Gazdoin, M., Malik, A., Reis, E. D., Fallon, J. T., Badimon, J. J., Charo, I. F., and Taubman, M. B. (2002) CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler. Thromb. Vasc. Biol. 22, 554-559.
14. Schepers, A., Eefting, D., Bonta, P. I., Grimbergen, J. M., de Vries, M. R., van Weel, V., de Vries, C. J., Egashira, K., van Bockel, J. H., and Quax, P. H. (2006) Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 26, 2063-2069.
15. Eefting, D., Bot, I., de Vries, M. R., Schepers, A., van Bockel, J. H., Van Berkel, T. J., Biessen, E. A., and Quax, P. H. (2009) Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice. J. Vasc. Surg. 50, 152-160.
16. Rahmani, M., Cruz, R. P., Granville, D. J., and McManus, B. M. (2006) Allograft vasculopathy versus atherosclerosis. Circ. Res. 99, 801-815.
17. Bursill, C. A., Castro, M. L., Beattie, D. T., Nakhla, S., van der Vorst, E., Heather, A. K., Barter, P. J., and Rye, K. A. (2010) High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 30, 1773-1778.
18. Nicholls, S. J., Dusting, G. J., Cutri, B., Bao, S., Drummond, G. R., Rye, K. A., and Barter, P. J. (2005) Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111, 1543- 1550.
19. Di Bartolo, B. A., Nicholls, S. J., Bao, S., Rye, K. A., Heather, A. K., Barter, P. J., and Bursill, C. (2011) The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis 217, 395-400.
20. Scanu, A., Oliviero, F., Gruaz, L., Sfriso, P., Pozzuoli, A., Frezzato, F., Agostini, C., Burger, D., and Punzi, L. (2010) High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals. Arthritis Res. Ther. 12, R23.
21. Ibanez, B., Giannarelli, C., Cimmino, G., Santos-Gallego, C. G., Alique, M., Pinero, A., Vilahur, G., Fuster, V., Badimon, L., and Badimon, J. J. (2012) Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL- (wild-type). Atherosclerosis 220, 72-77.
22. Weisweiler, P. (1987) Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. Clin. Chim. Acta 169, 249- 254.
23. Matz, C. E., and Jonas, A. (1982) Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257, 4535-4540.
24. Takayama, M., Itoh, S., Nagasaki, T., and Tanimizu, I. (1977) A new enzymatic method for determination of serum cholinecontaining phospholipids. Clin. Chim. Acta 79, 93-98.
25. McGrath, K. C., Li, X. H., Puranik, R., Liong, E. C., Tan, J. T., Dy, V. M., DiBartolo, B. A., Barter, P. J., Rye, K. A., and Heather, A. K. (2009) Role of 3beta-hydroxysteroid-delta 24 reductase in mediating anti-inflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 877-882.
26. Shimizu, K., Minami, M., Shubiki, R., Lopez-Ilasaca, M., Mac- Farlane, L., Asami, Y., Li, Y., Mitchell, R. N., and Libby, P. (2009) CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease. Circulation 120, 1800-1813.
27. Topakian, R., Sonnberger, M., Nussbaumer, K., Haring, H. P., Trenkler, J., and Aichner, F. T. (2008) Postprocedural highdensity lipoprotein cholesterol predicts carotid stent patency at 1 year. Eur. J. Neurol. 15, 179-184.
28. Seo, S. M., Choo, E. H., Koh, Y. S., Park, M. W., Shin, D. I., Choi, Y. S., Park, H. J., Kim, D. B., Her, S. H., Lee, J. M., Park, C. S., Kim, P. J., Moon, K. W., Chang, K., Kim, H. Y., Yoo, K. D., Jeon, D. S., Chung, W. S., Park, Y. G., and Seung, K. B. (2011) High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention. Heart 97, 1943-1950.
29. Robbesyn, F., Garcia, V., Auge, N., Vieira, O., Frisach, M. F., Salvayre, R., and Negre-Salvayre, A. (2003) HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J. 17, 743-745.
30. Mineo, C., and Shaul, P. W. (2007) Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair. Trends Cardiovasc. Med. 17, 156-161.
31. Seetharam, D., Mineo, C., Gormley, A. K., Gibson, L. L., Vongpatanasin, W., Chambliss, K. L., Hahner, L. D., Cummings, M. L., Kitchens, R. L., Marcel, Y. L., Rader, D. J., and Shaul, P. W. (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ. Res. 98, 63-72.
32. Feng, Y., van Eck, M., Van Craeyveld, E., Jacobs, F., Carlier, V., Van Linthout, S., Erdel, M., Tjwa, M., and De Geest, B. (2009) Critical role of scavenger receptor-BI-expressing bone marrowderived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 113, 755-764.
33. Murphy, A. J., Hoang, A., Aprico, A., Sviridov, D., and Chin- Dusting, J. (2012) Anti-inflammatory functions of apolipoprotein A-I and HDL are preserved in trimeric apolipoprotein A-I. [E-pub ahead of print] J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.112.199257.
34. Murphy, A. J., Akhtari, M., Tolani, S., Pagler, T., Bijl, N., Kuo, C. L., Wang, M., Sanson, M., Abramowicz, S., Welch, C., Bochem, A. E., Kuivenhoven, J. A., Yvan-Charvet, L., and Tall, A. R. (2011) ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J. Clin. Invest. 121, 4138-4149.
35. Gonzalez-Diez, M., Rodriguez, C., Badimon, L., and Martinez- Gonzalez, J. (2008) Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. Thromb. Haemost. 100, 119-126.
36. Sviridov, D., Fidge, N., Beaumier-Gallon, G., and Fielding, C. (2001) Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae). Biochem. J. 358, 79-86.
37. Ashby, D. T. R. K., Clay, M. A., Vadas, M. A., Gamble, J. R., Barter, P. J. (1998) Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18, 1450-1455.
38. Baker, P. W., Rye, K. A., Gamble, J. R., Vadas, M. A., and Barter, P. J. (1999) Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid Res. 40, 345-353.
39. Saddar, S., Carriere, V., Lee, W. R., Tanigaki, K., Yuhanna, I. S., Parathath, S., Morel, E., Warrier, M., Sawyer, J. K., Gerard, R. D., Temel, R. E., Brown, J. M., Connelly, M., Mineo, C., and Shaul, P. W. (2012) Scavenger receptor class B Type I (SR-BI) is a plasma membrane cholesterol sensor. [E-pub ahead of print] Circ. Res. doi: 10.1161/CIRCRESAHA.112.280081.